SterEotactic AbLative Radiotherapy in PatiEnts With HypertrophiC ObstrucTive Cardiomyopathy
Condition(s):Hypertrophic Obstructive CardiomyopathyLast Updated:November 30, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Hypertrophic Obstructive CardiomyopathyLast Updated:November 30, 2022Completed
Condition(s):Cardiac ArrhythmiaLast Updated:March 13, 2024Recruiting
Condition(s):Radiotherapy; Complications; Ventricular Tachycardia; Structural Heart Abnormality; Heart FailureLast Updated:January 25, 2023Recruiting
Condition(s):NSCLC; NSCLC Stage IV; Oligometastatic Disease; Non Small Cell Lung Cancer; Non Small Cell Lung Cancer Metastatic; EGF-R Positive Non-Small Cell Lung Cancer; NSCLC Stage IV Without EGFR/ALK Mutation; Non-Small Cell Adenocarcinoma; Non-Small Cell Squamous Lung Cancer; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor; Synchronous Metastases; Metachronous MetastasisLast Updated:January 16, 2024Recruiting
Condition(s):Metastasis of Malignant Neoplasm to Lymph NodeLast Updated:March 11, 2019Unknown status
Condition(s):Hepatocellular CarcinomaLast Updated:September 20, 2019Unknown status
Condition(s):Hepatocellular Carcinoma; Portal Vein Tumor ThrombusLast Updated:September 20, 2019Completed
Condition(s):Tachycardia, VentricularLast Updated:August 17, 2022Withdrawn
Condition(s):Locally Advanced Lung Non-Small Cell CarcinomaLast Updated:March 23, 2022Completed
Condition(s):Prostate CancerLast Updated:February 12, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.